Tellgen Corp (300642) - Net Assets

Latest as of September 2025: CN¥1.53 Billion CNY ≈ $223.58 Million USD

Based on the latest financial reports, Tellgen Corp (300642) has net assets worth CN¥1.53 Billion CNY (≈ $223.58 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥2.00 Billion ≈ $292.77 Million USD) and total liabilities (CN¥472.84 Million ≈ $69.19 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check financial resilience of Tellgen Corp to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥1.53 Billion
% of Total Assets	76.37%
Annual Growth Rate	28.85%
5-Year Change	19.85%
10-Year Change	689.31%
Growth Volatility	55.1

Tellgen Corp - Net Assets Trend (2012–2024)

This chart illustrates how Tellgen Corp's net assets have evolved over time, based on quarterly financial data. Also explore 300642 current and non-current assets for the complete picture of this company's asset base.

Annual Net Assets for Tellgen Corp (2012–2024)

The table below shows the annual net assets of Tellgen Corp from 2012 to 2024. For live valuation and market cap data, see how much is Tellgen Corp worth.

Year	Net Assets	Change
2024-12-31	CN¥1.52 Billion ≈ $222.14 Million	-1.15%
2023-12-31	CN¥1.54 Billion ≈ $224.72 Million	+3.72%
2022-12-31	CN¥1.48 Billion ≈ $216.67 Million	+6.04%
2021-12-31	CN¥1.40 Billion ≈ $204.32 Million	+10.24%
2020-12-31	CN¥1.27 Billion ≈ $185.34 Million	+8.38%
2019-12-31	CN¥1.17 Billion ≈ $171.01 Million	+14.11%
2018-12-31	CN¥1.02 Billion ≈ $149.87 Million	+14.32%
2017-12-31	CN¥895.86 Million ≈ $131.09 Million	+210.36%
2016-12-31	CN¥288.65 Million ≈ $42.24 Million	+50.09%
2015-12-31	CN¥192.33 Million ≈ $28.14 Million	+46.76%
2014-12-31	CN¥131.05 Million ≈ $19.18 Million	+37.88%
2013-12-31	CN¥95.04 Million ≈ $13.91 Million	+31.15%
2012-12-31	CN¥72.47 Million ≈ $10.60 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Tellgen Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 16316.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Retained Earnings	CN¥807.70 Million	53.58%
Common Stock	CN¥163.02 Million	10.81%
Other Components	CN¥536.77 Million	35.61%
Total Equity	CN¥1.51 Billion	100.00%

Tellgen Corp Competitors by Market Cap

The table below lists competitors of Tellgen Corp ranked by their market capitalization.

Company	Market Cap
Guangdong Hongteo Accurate Technology Co Ltd SHE:300176	$392.73 Million
Holtek Semiconductor Inc TW:6202	$392.78 Million
PetroVietnam Transportation Corp VN:PVT	$392.80 Million
Autocanada Inc TO:ACQ	$393.00 Million
PHX Energy Services Corporation TO:PHX	$392.59 Million
VT Industrial Technology Co Ltd SHE:300707	$392.41 Million
Vaibhav Global Limited NSE:VAIBHAVGBL	$392.20 Million
Jilin Jlu Communication Design Institute Co Ltd SHE:300597	$392.08 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Tellgen Corp's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 1,528,514,000 to 1,507,493,000, a change of -21,021,000 (-1.4%).
Net income of 34,534,998 contributed positively to equity growth.
Dividend payments of 25,618,000 reduced retained earnings.
Share repurchases of 12,568,302 reduced equity.
Other comprehensive income decreased equity by 83,198,690.
Other factors increased equity by 65,828,994.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	CN¥34.53 Million	+2.29%
Dividends Paid	CN¥25.62 Million	-1.7%
Share Repurchases	CN¥12.57 Million	-0.83%
Other Comprehensive Income	CN¥-83.20 Million	-5.52%
Other Changes	CN¥65.83 Million	+4.37%
Total Change	CN¥-	-1.38%

Book Value vs Market Value Analysis

This analysis compares Tellgen Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.78x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 27.68x to 1.78x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2012-12-31	CN¥0.60	CN¥16.51	x
2013-12-31	CN¥0.78	CN¥16.51	x
2014-12-31	CN¥1.08	CN¥16.51	x
2015-12-31	CN¥1.58	CN¥16.51	x
2016-12-31	CN¥2.37	CN¥16.51	x
2017-12-31	CN¥6.03	CN¥16.51	x
2018-12-31	CN¥6.31	CN¥16.51	x
2019-12-31	CN¥7.19	CN¥16.51	x
2020-12-31	CN¥7.77	CN¥16.51	x
2021-12-31	CN¥8.48	CN¥16.51	x
2022-12-31	CN¥9.05	CN¥16.51	x
2023-12-31	CN¥9.37	CN¥16.51	x
2024-12-31	CN¥9.30	CN¥16.51	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Tellgen Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 2.29%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 7.91%
• Asset Turnover: 0.25x
• Equity Multiplier: 1.16x
Recent ROE (2.29%) is below the historical average (16.71%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2012	18.79%	27.96%	0.60x	1.12x	CN¥6.37 Million
2013	23.75%	29.39%	0.60x	1.35x	CN¥13.07 Million
2014	27.47%	30.46%	0.73x	1.23x	CN¥22.90 Million
2015	34.20%	38.83%	0.73x	1.20x	CN¥46.55 Million
2016	33.87%	42.28%	0.68x	1.18x	CN¥68.90 Million
2017	14.16%	41.87%	0.32x	1.04x	CN¥37.23 Million
2018	13.83%	38.84%	0.33x	1.08x	CN¥39.28 Million
2019	13.44%	35.57%	0.35x	1.07x	CN¥40.15 Million
2020	9.52%	24.62%	0.36x	1.08x	CN¥-6.11 Million
2021	11.56%	24.61%	0.44x	1.08x	CN¥21.70 Million
2022	8.47%	17.42%	0.43x	1.13x	CN¥-22.48 Million
2023	5.85%	16.47%	0.32x	1.10x	CN¥-63.45 Million
2024	2.29%	7.91%	0.25x	1.16x	CN¥-116.21 Million

Industry Comparison

This section compares Tellgen Corp's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

Industry: Medical Devices
Average net assets among peers: $1,693,665,971
Average return on equity (ROE) among peers: 12.72%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Tellgen Corp (300642)	CN¥1.53 Billion	18.79%	0.31x	$392.70 Million
Shanghai Kehua Bio-Engineering Co Ltd (002022)	$486.48 Million	24.26%	0.26x	$449.34 Million
Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223)	$405.69 Million	15.24%	0.11x	$4.30 Billion
Double Medical Technology Inc (002901)	$3.16 Billion	1.87%	0.47x	$2.63 Billion
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932)	$49.59 Million	43.44%	0.23x	$577.41 Million
Lepu Medical Tech Beijing (300003)	$6.01 Billion	11.30%	0.58x	$3.87 Billion
INKON Life Technology Co Ltd (300143)	$116.90 Million	17.41%	0.92x	$1.23 Billion
Edan Instruments Inc (300206)	$1.22 Billion	8.49%	0.19x	$1.26 Billion
Guangdong Biolight Meditech Co Ltd (300246)	$1.39 Billion	-4.69%	0.82x	$685.28 Million
Beijing Leadman Biochemistry Co Ltd (300289)	$1.45 Billion	0.44%	0.18x	$534.16 Million
Sinocare Inc (300298)	$2.65 Billion	9.46%	0.24x	$1.36 Billion

About Tellgen Corp

SHE:300642 China Medical Devices

Market Cap

$392.70 Million

CN¥2.68 Billion CNY

Market Cap Rank

#13773 Global

#4340 in China

Share Price

CN¥16.51

Change (1 day)

+0.30%

52-Week Range

CN¥13.71 - CN¥31.30

All Time High

CN¥46.24